0001830547--12-312021Q3false00007762500776250000.330776250000310500000001830547ssaau:PublicWarrantsMember2021-09-300001830547ssaau:CommonClassaSubjectToRedemptionMember2020-12-310001830547ssaau:CommonClassaSubjectToRedemptionMember2021-09-300001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaSubjectToRedemptionMember2021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaSubjectToRedemptionMember2021-06-300001830547ssaau:CommonClassaSubjectToRedemptionMember2021-06-300001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaSubjectToRedemptionMember2021-03-310001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaSubjectToRedemptionMember2021-03-310001830547ssaau:CommonClassaSubjectToRedemptionMember2021-03-310001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaSubjectToRedemptionMember2021-01-280001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaSubjectToRedemptionMember2021-01-280001830547ssaau:CommonClassaSubjectToRedemptionMember2021-01-280001830547ssaau:FounderSharesMemberssaau:SponsorMemberus-gaap:CommonClassBMember2020-10-292020-10-290001830547us-gaap:RetainedEarningsMember2021-09-300001830547us-gaap:RetainedEarningsMember2021-06-300001830547us-gaap:RetainedEarningsMember2021-03-310001830547us-gaap:RetainedEarningsMember2020-12-310001830547us-gaap:AdditionalPaidInCapitalMember2020-12-310001830547ssaau:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001830547ssaau:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001830547ssaau:PublicAndPrivatePlacementWarrantsMember2021-09-300001830547us-gaap:OverAllotmentOptionMember2021-01-280001830547us-gaap:IPOMember2021-01-280001830547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-09-300001830547ssaau:CommonClassaSubjectToRedemptionMemberus-gaap:CommonStockMember2021-09-300001830547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-06-300001830547ssaau:CommonClassaSubjectToRedemptionMemberus-gaap:CommonStockMember2021-06-300001830547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-310001830547ssaau:CommonClassaSubjectToRedemptionMemberus-gaap:CommonStockMember2021-03-310001830547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-12-3100018305472021-06-3000018305472021-03-310001830547ssaau:PromissoryNoteWithRelatedPartyMember2021-02-022021-02-020001830547ssaau:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-01-282021-01-280001830547ssaau:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-01-012021-09-300001830547us-gaap:RetainedEarningsMember2021-07-012021-09-300001830547us-gaap:RetainedEarningsMember2021-04-012021-06-300001830547us-gaap:FairValueInputsLevel3Member2021-09-300001830547ssaau:PrivatePlacementWarrantsMember2021-09-300001830547ssaau:NonRedeemableClassBCommonStockMember2021-07-012021-09-300001830547ssaau:CommonClassaSubjectToRedemptionMember2021-07-012021-09-300001830547srt:ScenarioPreviouslyReportedMemberssaau:NonRedeemableClassBCommonStockMember2021-04-012021-06-300001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaSubjectToRedemptionMember2021-04-012021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:NonRedeemableClassBCommonStockMember2021-04-012021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaSubjectToRedemptionMember2021-04-012021-06-300001830547ssaau:NonRedeemableClassBCommonStockMember2021-04-012021-06-300001830547ssaau:CommonClassaSubjectToRedemptionMember2021-04-012021-06-300001830547ssaau:NonRedeemableClassBCommonStockMember2021-01-012021-09-300001830547srt:ScenarioPreviouslyReportedMemberssaau:NonRedeemableClassBCommonStockMember2021-01-012021-06-300001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:NonRedeemableClassBCommonStockMember2021-01-012021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-06-300001830547ssaau:NonRedeemableClassBCommonStockMember2021-01-012021-06-300001830547ssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-06-300001830547srt:ScenarioPreviouslyReportedMemberssaau:NonRedeemableClassBCommonStockMember2021-01-012021-03-310001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-03-310001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:NonRedeemableClassBCommonStockMember2021-01-012021-03-310001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-03-310001830547ssaau:NonRedeemableClassBCommonStockMember2021-01-012021-03-310001830547ssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-03-310001830547us-gaap:MeasurementInputSharePriceMember2021-09-300001830547us-gaap:MeasurementInputRiskFreeInterestRateMember2021-09-300001830547us-gaap:MeasurementInputPriceVolatilityMember2021-09-300001830547us-gaap:MeasurementInputExpectedTermMember2021-09-300001830547us-gaap:MeasurementInputExercisePriceMember2021-09-300001830547ssaau:MeasurementInputNumberOfTrialsMember2021-09-300001830547us-gaap:MeasurementInputSharePriceMember2021-01-280001830547us-gaap:MeasurementInputRiskFreeInterestRateMember2021-01-280001830547us-gaap:MeasurementInputPriceVolatilityMember2021-01-280001830547us-gaap:MeasurementInputExpectedTermMember2021-01-280001830547us-gaap:MeasurementInputExercisePriceMember2021-01-280001830547ssaau:MeasurementInputNumberOfTrialsMember2021-01-2800018305472021-07-012021-09-300001830547srt:ScenarioPreviouslyReportedMemberus-gaap:CommonClassBMember2021-06-300001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaNotSubjectToRedemptionMember2021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaNotSubjectToRedemptionMember2021-06-300001830547us-gaap:CommonClassBMember2021-06-300001830547srt:ScenarioPreviouslyReportedMemberus-gaap:CommonClassBMember2021-03-310001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaNotSubjectToRedemptionMember2021-03-310001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaNotSubjectToRedemptionMember2021-03-310001830547us-gaap:CommonClassBMember2021-03-310001830547srt:ScenarioPreviouslyReportedMemberus-gaap:CommonClassBMember2021-01-280001830547srt:ScenarioPreviouslyReportedMemberssaau:CommonClassaNotSubjectToRedemptionMember2021-01-280001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberssaau:CommonClassaNotSubjectToRedemptionMember2021-01-280001830547us-gaap:CommonClassBMember2021-01-280001830547us-gaap:CommonClassBMember2020-12-310001830547ssaau:CommonClassaNotSubjectToRedemptionMember2020-12-310001830547ssaau:FounderSharesMemberssaau:SponsorMemberus-gaap:CommonClassBMember2021-01-252021-01-250001830547ssaau:PublicWarrantsMemberus-gaap:IPOMember2021-01-280001830547us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001830547srt:ScenarioPreviouslyReportedMember2021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-06-300001830547srt:ScenarioPreviouslyReportedMember2021-03-310001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-03-310001830547srt:ScenarioPreviouslyReportedMember2021-01-280001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-01-280001830547us-gaap:OverAllotmentOptionMember2021-01-282021-01-280001830547ssaau:CommonClassaSubjectToRedemptionMemberus-gaap:CommonStockMember2021-01-012021-03-310001830547us-gaap:CommonClassAMember2021-01-012021-03-310001830547ssaau:CommonClassaSubjectToRedemptionMember2021-01-012021-09-300001830547srt:ScenarioPreviouslyReportedMember2021-04-012021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-04-012021-06-3000018305472021-04-012021-06-300001830547srt:ScenarioPreviouslyReportedMember2021-01-282021-01-280001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-01-282021-01-2800018305472021-01-282021-01-280001830547ssaau:FounderSharesMemberssaau:SponsorMemberus-gaap:CommonClassBMember2021-01-012021-09-300001830547ssaau:PrivatePlacementWarrantsMember2021-01-012021-09-300001830547ssaau:AdministrativeSupportAgreementMember2021-01-012021-09-300001830547ssaau:PublicWarrantsMemberus-gaap:CommonClassAMember2021-01-012021-09-300001830547us-gaap:IPOMember2021-01-282021-01-280001830547ssaau:PublicWarrantsMemberus-gaap:IPOMember2021-01-282021-01-280001830547ssaau:RestatementOfCommonStockSubjectToRedemptionMember2021-09-300001830547ssaau:RelatedPartyLoansMember2021-09-300001830547ssaau:PromissoryNoteWithRelatedPartyMember2020-10-290001830547us-gaap:FairValueInputsLevel3Member2021-01-012021-09-3000018305472021-01-280001830547us-gaap:CommonClassBMember2021-01-012021-09-300001830547us-gaap:CommonClassBMember2021-09-300001830547ssaau:CommonClassaNotSubjectToRedemptionMember2021-09-300001830547ssaau:WorkingCapitalLoansWarrantMemberssaau:RelatedPartyLoansMember2021-09-300001830547ssaau:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-09-300001830547ssaau:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-01-280001830547ssaau:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Memberssaau:PublicWarrantsMember2021-01-012021-09-300001830547ssaau:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Memberssaau:PublicWarrantsMember2021-01-012021-09-300001830547ssaau:PublicWarrantsMember2021-01-012021-09-300001830547srt:ScenarioPreviouslyReportedMember2021-01-012021-06-300001830547srt:ScenarioPreviouslyReportedMember2021-01-012021-03-310001830547ssaau:FounderSharesMemberssaau:SponsorMemberus-gaap:CommonClassBMember2021-01-2500018305472021-09-3000018305472020-12-310001830547us-gaap:RetainedEarningsMember2021-01-012021-03-310001830547us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-01-012021-06-3000018305472021-01-012021-06-300001830547srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-01-012021-03-3100018305472021-01-012021-03-310001830547us-gaap:CommonClassAMember2021-01-012021-09-300001830547ssaau:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember2021-01-012021-09-300001830547ssaau:UnitEachConsistingOfOneClassCommonStockAndOneThirdRedeemableWarrantMember2021-01-012021-09-300001830547us-gaap:CommonClassBMember2021-11-150001830547us-gaap:CommonClassAMember2021-11-1500018305472021-01-012021-09-30xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharesssaau:itemssaau:Vote

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-39930

Science Strategic Acquisition Corp. Alpha

(Exact name of registrant as specified in its charter)


Delaware		85-3594633
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1447 2nd Street

Santa Monica, CA 90401

(Address of principal executive offices including zip code)

Registrant’s telephone number, including area code: (310) 393-3024

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one redeemable warrant	SSAAU	The Nasdaq Stock Market LLC
Class A common stock	SSAA	The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50	SSAAW	The Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 15, 2021, the Registrant had 31,050,000 shares of Class A common stock, par value $0.0001 per share, and 7,762,500 shares of Class B common stock, par value $0.0001 per share, issued and outstanding.

Table of Contents

SCIENCE STRATEGIC ACQUISITION CORP. ALPHA

Table of Contents

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Condensed Balance Sheets as of September 30, 2021 (unaudited) and December 31, 2020	1
	Condensed Statement of Operations for the three and nine months ended September 30, 2021 (unaudited)	2
	Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2021 (unaudited)	3
	Condensed Statement of Cash Flows for the nine months ended September 30, 2021 (unaudited)	4
	Notes to Interim Condensed Financial Statements (unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	23
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Use of Proceeds	24
Item 3.	Defaults Upon Senior Securities	24
Item 4.	Mine Safety Disclosures	24
Item 5.	Other Information	24
Item 6.	Exhibits	25
Signatures		26

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Science Strategic Acquisition Corp. Alpha

Condensed Balance Sheets


	September 30,		December 31,
	2021		2020
	(unaudited)
ASSETS
Current assets
Cash	$	738,396	$	20,000
Deferred offering costs		—		183,912
Prepaid expenses		462,361		—
Total Current Assets		1,200,757		203,912

Marketable securities held in Trust Account		310,538,740		—
TOTAL ASSETS	$	311,739,497	$	203,912

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accrued offering costs	$	70,000	$	151,812
Accrued offering costs - related party		—		27,100
Accrued expenses		543,673		5,000
Total Current Liabilities		613,673		183,912

Warrant liability		11,699,443		—
Deferred underwriting fee payable		10,867,500		—
Total Liabilities		23,180,616		183,912

Commitments

Class A Common stock subject to possible redemption, 31,050,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively		310,500,000		—

Stockholders' Equity
Preferred stock, $0.0001 par value; 1,000,000 authorized; none issued and outstanding		—		—
Class A Common stock, $0.0001 par value; 400,000,000 shares authorized; no shares issued and outstanding (excluding 31,050,000 and no shares subject to possible redemption) as of September 30, 2021 and December 31, 2020, respectively		—		—
Class B Common stock, $0.0001 par value; 40,000,000 shares authorized; 7,762,500 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively		776		776
Additional paid-in capital		—		24,224
Accumulated deficit		(21,941,895)		(5,000)
Total Stockholders’ Equity (Deficit)		(21,941,119)		20,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	311,739,497	$	203,912

See accompanying notes to interim condensed financial statements.

Table of Contents

Science Strategic Acquisition Corp. Alpha

Condensed Statement of Operations

For the three and nine months ended September 30, 2021

(Unaudited)


	For the		For the
	Three Months Ended		Nine months Ended
	September 30,		September 30,
	2021		2021
Operating costs	$	706,140	$	1,435,614
Loss from operations		(706,140)		(1,435,614)

Other income (loss):
Unrealized gain on marketable securities held in Trust Account		3,996		38,740
Change in fair value of warrant liability		1,835,325		(93,677)
Other income (loss), net		1,839,321		(54,937)

Gain (Loss) before provision for income taxes		1,133,181		(1,490,551)
Provision for income taxes		—		—
Net Gain (Loss)	$	1,133,181	$	(1,490,551)

Weighted average shares outstanding of redeemable Class A common stock		31,050,000		27,763,686

Basic and diluted net earnings (loss) per share, redeemable Class A common stock	$	0.03	$	(0.04)

Weighted average shares outstanding of nonredeemable Class B common stock		7,762,500		7,655,338

Basic and diluted Earnings (net loss) per share, nonredeemable Class B common stock	$	0.03	$	(0.04)

See accompanying notes to interim condensed financial statements.

Table of Contents

Science Strategic Acquisition Corp. Alpha

Condensed Statement of Changes in Stockholders’ Equity (Deficit)

(Unaudited)


	Class A Common
	Shares Subject to			Class A			Class B				Additional				Total
	Possible Redemption			Common Stock			Common Stock				Paid in		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Shares		Amount		Capital		Deficit		Equity (Deficit)
Balance — January 1, 2021	—	$	—	—	$	—		7,762,500	$	776	$	24,224	$	(5,000)	$	20,000
Sale of 31,050,000 Units	31,050,000		310,500,000	—		—		—		—		—		—		—
Proceeds Received in Excess of Fair Value of Private Warrants	—		—	—		—		—		—		4,159,734		—		4,159,734
Accretion of Class A common stock subject to redemption (see Note 2)	—			—		—						(4,183,958)		(20,446,345)		(24,630,303)
Net income	—		—	—		—		—		—	$			1,567,374		1,567,374
Balance — March 31, 2021 as restated (see Note 2)	31,050,000	$	310,500,000	—	$	—		7,762,500	$	776		—	$	(18,883,971)	$	(18,883,195)
Net loss	—			—		—		—		—				(4,191,105)		(4,191,105)
Balance – June 30, 2021 as restated (see Note 2)	31,050,000	$	310,500,000	—	$	—		7,762,500	$	776	$	—	$	(23,075,076)	$	(23,074,300)
Net income	—			—		—		—		—				1,133,181		1,133,181
Balance – September 30, 2021	31,050,000	$	310,500,000	—	$	—		7,762,500	$	776	$	—	$	(21,941,895)	$	(21,941,119)

See accompanying notes to interim condensed financial statements.

Table of Contents

Science Strategic Acquisition Corp. Alpha

Condensed Statement of Cash Flows

For the Nine months Ended September 30, 2021

(Unaudited)


Cash Flows used in Operating Activities:
Net loss	$	(1,490,551)
Adjustments to reconcile net income to net cash used in operating activities:
Unrealized gain on marketable securities held in Trust Account		(38,740)
Change in fair value of warrant liabilities		93,677

Changes in operating assets and liabilities:
Prepaid expenses		(462,362)
Accrued expenses		538,673
Net cash used in operating activities		(1,359,303)

Cash Flows from Investing Activities:
Investment of cash in Trust Account		(310,500,000)
Net cash used in investing activities		(310,500,000)

Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		304,710,744
Proceeds from the sale of Private Placements Warrants		8,210,000
Proceeds from promissory note — related party		300,000
Repayment of promissory note — related party		(300,000)
Payment of offering costs		(343,045)
Net cash provided by financing activities		312,577,699

Net Change in Cash		718,396
Cash — Beginning of period		20,000
Cash — End of period	$	738,396

Supplemental cash flow information:
Cash paid for income taxes	$	—

Non-Cash investing and financing activities:
Initial fair value of warrant liability	$	11,605,766
Deferred offering cost included in accrued offering cost	$	70,000
Accretion of Class A common stock subject to possible redemption as restated due to the treatment of Class A common stock subject to possible redemption (see note 2)	$	24,630,303

See accompanying notes to interim condensed financial statements.

Table of Contents

Science Strategic Acquisition Corp. Alpha

Notes to Interim Condensed Financial Statements

Unaudited

NOTE 1. ORGANIZATION AND PLANS OF BUSINESS OPERATIONS

Organization and General

Science Strategic Acquisition Corp. Alpha (the “Company”) was incorporated in Delaware on October 22, 2020. The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”).

Sponsor and Initial Financing

As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering, and non-operating income or expenses from the change in fair value of warrant liabilities.

The registration statements for the Initial Public Offering were declared effective on January 25, 2021. On January 28, 2021, the Company consummated the Initial Public Offering of 31,050,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the exercise by the underwriter of its over-allotment option in the amount of 4,050,000 Units, at $10.00 per Unit, generating gross proceeds of $310,500,000, which is described in Note 4.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 5,473,333 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to SSAC Alpha Sponsor, LLC (the “Sponsor”), generating gross proceeds of $8,210,000, which is described in Note 5.

Transaction costs amounted to $17,495,500, consisting of $6,210,000 of underwriting fees, $10,867,500 of deferred underwriting fees and $418,000 of other offering costs. In addition, cash of approximately $2,300,000 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes.

The Trust Account

Following the closing of the Initial Public Offering on January 28, 2021, an amount of $310,500,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”). The funds in the Trust Account will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account will not otherwise be released from the trust account until the earliest of: (1) the Company’s completion of a Business Combination; (2) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete a Business Combination on or before January 28, 2023 or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity; and (3) the redemption of the Company’s Public Shares if the Company has not completed a Business Combination on or before January 28, 2023, subject to applicable law. Based on current interest rates, the Company expects that interest earned on the trust account will be sufficient to pay taxes.

Table of Contents

Business Combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds from the Initial Public Offering, although substantially all of the net proceeds from the Initial Public Offering are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” means one or more target businesses that together have an aggregate fair market value equal to at least 80% of the value of the assets held in the Trust Account (excluding taxes payable on the interest earned on the Trust Account) at the time of the signing of a definitive agreement in connection with a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination, either (i) in connection with a stockholder meeting called to approve such Business Combination or (ii) by means of a tender offer. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to the public stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The decision as to whether the Company will seek stockholder approval of a Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by law or stock exchange listing requirements. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the shares of common stock voted are voted in favor of a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination.

The Company will have until January 28, 2023 to complete its initial Business Combination. If the Company does not complete a Business Combination by such date (or such longer period as provided in an amendment to the Company’s amended and restated certificate of incorporation approved by its stockholders (an “Extension Period”)), it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete its initial Business Combination by January 28, 2023 or during any Extension Period. The initial stockholders have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to their Founder Shares (as defined in Note 6) if the Company fails to complete its initial Business Combination by January 28, 2023 or during any Extension Period. However, if the initial stockholders acquire Public Shares, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete its initial Business Combination by January 28, 2023 or during any Extension Period.

Table of Contents

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claims of any kind in or to any monies held in the Trust Account.

Liquidity and Capital Resources

As of September 30, 2021, the Company had $738,396 cash held outside of the Trust Account and working capital of $737,084.

The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover certain offering costs on the Company’s behalf in exchange for the issuance of Founder Shares (as discussed in Note 6), and a loan from the Sponsor of $300,000 under the Promissory Note (as discussed in Note 6). The Company repaid the Promissory Note in full on February 2, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the private placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as discussed in Note 6). As of September 30, 2021, there were no working capital loans outstanding.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from the date the financial statements are issued. Over this time period, the Company will use these funds to pay existing accounts payable, identify and evaluate prospective initial Business Combination candidates, perform due diligence on prospective target businesses, pay for travel expenditures, select a target business to merge with or acquire, and structure, negotiate and consummate the Business Combination.

NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

In connection with the preparation of the Company’s financial statements as of September 30, 2021, management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company improperly valued its Class A common stock subject to possible redemption. The Company previously determined the Class A common stock subject to possible redemption to be equal to the redemption value, while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the redemption value should include all shares of Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has noted a reclassification error related to temporary equity and permanent equity. This resulted in a restatement of the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.

In connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its income (loss) per ordinary share calculation to allocate net income (loss) evenly to Class A and Class B common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the income (loss) of the Company.

The restatements do not result in any changes in the Company’s total assets, liabilities or operating results.

Table of Contents

The impact of the restatement on the Company’s financial statements is reflected in the following table.


	As Previously
Balance Sheet as of January 28, 2021 (audited)	Reported		Adjustment		As Restated
Class A common stock subject to possible redemption	$	284,624,724	$	25,875,276	$	310,500,000
Class A common stock	$	259	$	(259)	$	—
Class B common stock	$	777	$	—	$	777
Additional paid-in capital	$	5,424,718	$	(5,424,718)	$	—
Accumulated deficit	$	(425,744)	$	(20,450,299)	$	(20,876,043)
Total Shareholders’ Equity (Deficit)	$	5,000,010	$	(25,875,276)	$	(20,875,266)
Number of shares subject to redemption		28,462,472		2,587,528		31,050,000

Condensed Balance Sheet as of March 31, 2021 (unaudited)
Class A common stock subject to possible redemption	$	286,616,795	$	23,883,205	$	310,500,000
Class A common stock	$	239	$	(239)	$	—
Class B common stock	$	776	$	—	$	776
Additional paid-in capital	$	3,436,621	$	(3,436,621)	$	—
Accumulated deficit	$	1,562,374	$	(20,446,345)	$	(18,883,971)
Total Shareholders’ Equity (Deficit)	$	5,000,010	$	(23,883,205)	$	(18,883,195)
Number of shares subject to redemption		28,659,098		2,390,902		31,050,000

Condensed Balance Sheet as of June 30, 2021 (unaudited)
Class A common stocksubject to possible redemption	$	282,425,690	$	28,074,310	$	310,500,000
Class A common stock	$	281	$	(281)	$	—
Class B common stock	$	776	$	—	$	776
Additional paid-in capital	$	7,627,684	$	(7,627,684)	$	—
Accumulated deficit	$	(2,628,731)	$	(20,446,345)	$	(23,075,076)
Total Shareholders’ Equity (Deficit)	$	5,000,010	$	(28,074,310)	$	(23,074,300)
Number of shares subject to redemption		28,240,098		2,809,902		31,050,000


	As Previously
	Reported		Adjustment		As Restated
Condensed Statement of Operations for the Three Months Ended March 31, 2021 (unaudited)
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		28,462,472		(7,307,527)		21,154,945
Basic and diluted net income per share, common stock subject to possible redemption	$	0.00		0.05	$	0.05
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		9,230,019		(1,790,184)		7,439,835
Basic and diluted net income per share, Non-redeemable common stock	$	0.17	$	(0.12)	$	0.05

Condensed Statement of Operations for the Three Months Ended June 30, 2021 (unaudited)
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		28,659,098		2,390,902		31,050,000
Basic and diluted net income per share common stock subject to possible redemption	$	0.00		(0.11)	$	(0.11)
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		10,153,402		(2,390,902)		7,762,500
Basic and diluted net loss per share, Non-redeemable common stock	$	(0.41)	$	0.30	$	(0.11)

Condensed Statement of Operations for the Six Months Ended June 30, 2021 (unaudited)
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		28,579,419		2,476,946		26,102,473
Basic and diluted net income per share, common stock subject to possible redemption	$	0.00		(0.08)	$	(0.08)
Basic and diluted weighted average shares outstanding, Non-redeemable common stock		9,694,261		(2,093,093)		7,601,168
Basic and diluted net income per share, Non-redeemable common stock	$	(0.27)	$	0.19	$	(0.08)

Condensed Statement of Cash Flows for the Three Months Ended March 31, 2021 (unaudited) Non-Cash investing and financing activities:
Change in value of Class A common stock subject to possible redemption	$	1,992,075	$	(1,992,075)	$	—
Accretion of Class A common stock subject to possible redemption	$	—	$	24,630,303	$	24,630,303

Condensed Statement of Cash Flows for the Six Months Ended June 30, 2021 (unaudited) Non-Cash investing and financing activities:
Change in value of Class A common stock subject to possible redemption	$	(2,199,030)	$	2,199,030	$	—
Accretion of Class A common stock subject to possible redemption	$	—	$	24,630,303	$	24,630,303

Table of Contents

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional capital, in accumulated deficit.

At September 30, 2021, the Class A common stock reflected in the condensed balance sheet is reconciled in the following table:


Gross proceeds		310,500,000
Less:
Proceeds allocated to public warrants		(7,555,500)
Class A common stock issuance costs		(17,074,803)
Add:
Accretion of carrying value to redemption value		24,630,303
Class A common stock subject to possible redemption, September 30, 2021		310,500,000

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC on April 7, 2021, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2020 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Table of Contents

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents consist of mutual funds. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.

Offering Costs

Offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. These costs, together with the upfront underwriting discounts, the deferred underwriting commissions and the financial advisory fee in connection with the Initial Public Offering were charged to stockholders’ equity and warrants exercisable for Class A common stock upon the completion of the Initial Public Offering. Approximately $17.1 million of the offering costs were related to the issuance of Class A common stock and charged to stockholders’ equity and approximately $0.4 million of the offering costs were related to the warrant liabilities and charged to the condensed statement of operations.

Marketable Securities Held in Trust Account

At September 30, 2021, substantially all of the assets held in the Trust Account were held in money market funds which invest in United States Treasury securities. Through September 30, 2021, the Company has not withdrawn any monies from the Trust Account.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

Table of Contents

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception.

On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOL”) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under section 163(j) of the Internal Revenue Code of 1986, as amended, from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company’s financial position or statement of operations.

Net Income (Loss) per Share

Net income (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Shares of common stock subject to possible redemption at September 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 15,823,333 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. As a result, diluted net loss per common share is the same as basic net loss per common share for the periods presented.

The Company’s statement of operations includes a presentation of net earnings (loss) per share of common stock subject to possible redemption and allocates the net income (loss) into the two classes of stock in calculating net earnings (loss) per Net earnings (loss) per common share, basic and diluted, for Class A redeemable common stock is calculated by dividing the net loss by the weighted average number of Class A common stock subject to possible redemption outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable common stock is calculated by dividing the net loss by the weighted average number of Class B non-redeemable common stock outstanding for the period. Class B non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

Table of Contents

The following table reflects the calculation of basic and diluted net earnings (loss) per common share (in dollars, except per share amounts):


			Nine months
	Three Months Ended		Ended
	September 30,		September 30,
	2021		2021
Class A Common Stock subject to possible redemption
Numerator: Earnings (loss) attributable to Class A Common Stock subject to possible redemption
Net income (loss)	$	906,545	$	(1,168,388)
Net earnings (loss) attributable to Class A Common Stock subject to possible redemption	$	906,545	$	(1,168,388)
Denominator: Weighted average Class A Common Stock subject to possible redemption
Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible redemption		31,050,000		27,763,686
Basic and diluted net earnings (loss) per share, Class A Common Stock subject to possible redemption	$	0.03	$	(0.04)
Non-Redeemable Class B Common Stock
Numerator: Net earnings (loss) minus net earnings
Net earnings (loss)	$	226,636	$	(322,162)
Non-redeemable net earnings (loss)	$	226,636		(322,162)

Denominator: Weighted average Non-Redeemable Class B Common Stock
Basic and diluted weighted average shares outstanding, Non-Redeemable Class B Common Stock		7,762,500		7,655,338

Basic and diluted net earnings (loss) per share, Non-Redeemable Class B Common Stock	$	0.03	$	(0.04)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement” (“ASC 820”), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

Warrants Exercisable for Class A Common Stock

The Company accounted for the 15,823,333 warrants issued in connection with the Initial Public Offering and the Private Placement Warrants (collectively, the “Warrants”) as either equity-classified or liability-classified instruments based on an assessment of the Warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

Table of Contents

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.

NOTE 4. INITIAL PUBLIC OFFERING

On January 28, 2021, pursuant to the Initial Public Offering, the Company sold 31,050,000 Units, which includes the full exercise by the underwriter of its over-allotment option in the amount of 4,050,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (each whole warrant, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 9).

NOTE 5. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 5,473,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $8,210,000 in a private placement. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at an exercise price of $11.50 per share. $6,210,000 of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination by January 28, 2023 or during any Extension Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

NOTE 6. RELATED PARTY TRANSACTIONS

Founder Shares

On October 29, 2020, the Sponsor purchased 6,468,750 Founder Shares (as defined below) for an aggregate purchase price of $25,000. On January 25, 2021, the Company effected a stock dividend of 1,293,750 shares of Class B common stock to holders of Class B common stock on a pro rata basis based on their holdings, resulting in the Company’s initial stockholders holding an aggregate of 7,762,500 Founder Shares.

The initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Class B common stock or Class A common stock received upon conversion thereof (together, “Founder Shares”) until the earlier of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Table of Contents

Promissory Note — Related Party

On October 29, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of December 31, 2021 or the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $300,000 remained outstanding at the closing of the Initial Public Offering on January 28, 2021. On February 2, 2021, the Company repaid the Promissory Note in full.

Administrative Services Agreement

The Company agreed, commencing on January 26, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, administrative and support services.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.50 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

NOTE 7. COMMITMENTS

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed in conjunction with the Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,867,500 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement by January 28, 2023.

NOTE 8. STOCKHOLDERS’ EQUITY

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. The Company’s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors is able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. At September 30, 2021, there were no shares of preferred stock issued or outstanding.

Table of Contents

Common Stock

Class A Common Stock — The Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, 2021, there were no shares of Class A common stock issued and outstanding, excluding 31,050,000 shares of Class A common stock subject to possible redemption which are presented as temporary equity.

Class B Common Stock —The Company is authorized to issue 40,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. At September 30, 2021, there were 7,762,500 shares of Class B common stock issued and outstanding.

Holders of Class B common stock have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

The Class B common stock will automatically convert into Class A common stock at the time of the completion of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Founder Shares will convert into Class A common stock will be adjusted (subject to waiver by holders of a majority of the Class B common stock) so that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the common stock issued and outstanding upon completion of the Initial Public Offering plus the number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in a Business Combination.

NOTE 9. WARRANTS

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months after the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement governing the Warrants (the “Warrant Agreement”). The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of the warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution form the Company’s assets held outside the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

Table of Contents

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of shares of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $18.00” and “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A common stock issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the Warrant Agreement. Notwithstanding the above, if the Class A common stock is, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that they do not satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $18.00. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

●

in whole and not in part;

●

at a price of $0.01 per Public Warrant;

●

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

●

if, and only if, the last reported sale price of shares of the Class A common stock for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant).

Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

●

in whole and not in part;

Table of Contents

●

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A common stock;

●

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and

●

if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants.

If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

The Private Placement Warrants are identical to the Public Warrants underlying the Units that were sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and are exercisable by such holders on the same basis as the Public Warrants.

The Warrants are not considered to be indexed to the Company’s stock price. In accordance with ASC 815, the warrants were classified as a liability in the total amount of $11.6 million at January 28, 2021. In addition, the warrants must be valued every reporting period and adjusted to market with the increase or decrease being adjusted through earnings. As of September 30, 2021 the fair value of the warrant liability was $11.7 million.

NOTE 10. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:

Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:

Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

Table of Contents

Level 1 assets and liabilities at fair value is comprised of Cash, Cash held in the Trust Account and Public Warrants. The Company has no other Level 1 assets or liabilities at fair value and no Level 2 assets or liabilities at fair value at September 30, 2021 and December 31, 2020. The Company has warrants exercisable for Class A common stock with a fair value of $11,699,443 and $0 as of September 30, 2021 and December 31, 2020, respectively. The Private Placement Warrants are classified as Level 3 based on a valuation model that utilizes both observable and unobservable inputs. Observable inputs include market prices of warrants issued by other special purpose acquisition companies and unobservable inputs include model adjustments for valuation uncertainty pertaining to the probability of the Company consummating a Business Combination. The Company transferred the fair value of Public Warrants from a Level 3 measurement to a Level 1 fair value measurement during the nine month periods ended September 30, 2021. The following table provides a summary of the changes in fair value of the Company’s Level 3 assets and liabilities for the nine months ended September 30, 2021. There were no transfers to/from Levels 1, 2 and 3 during the three months ended September 30, 2021.


	Private Placement Warrants
	Exercisable for
	Class A common
	stock		Public Warrants		Warrant Liabilities
Balance December 31, 2020	$	—	$	—	$	—
Initial Fair Value at January 28, 2021		4,050,266		7,555,500		11,605,766
Change in Fair Value		19,157		74,520		93,677
Transfer to Level 1		—		(7,630,020)		(7,630,020)
Fair Value as of September 30, 2021	$	4,069,423	$	—	$	4,069,423

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


		September 30,		December 31,
Description	Level	2021		2020
Assets:
Marketable securities held in Trust Account	1	$	310,538,740	$	—
Liabilities:
Public warrants	1	$	7,630,020	$	—
Private warrants	3	$	4,069,423	$	—

The Warrants were initially valued using a Monte Carlo simulation model, with the observable assumptions as provided in the table below. Significant increases in the expected stock prices and expected liquidity would result in a significantly higher fair value measurement. Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement. The measurement of the Public Warrants after the detachment of the Public Warrants from the Units is classified as Level 1 due to the use of an observable market quote in an active market. For periods subsequent to the detachment of the Public Warrants from the Units, the closing price of the Public Warrant was used as the fair value for the Public Warrants as of each relevant date.


	As of			As of
	January 28,			September 30,
	2021			2021

Stock price on valuation date	$	9.76		$	9.71
Exercise price	$	11.50		$	11.50
Term (years)		5.93			5.50
Expected volatility		14.0	%		12.9	%
Weighted average risk-free interest rate		0.57	%		1.06	%
Trials		400			400

Table of Contents

NOTE 11. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this quarterly report on Form 10-Q (the “Quarterly Report”) to “we,” “our,” “us,” and “Company” refer to Science Strategic Acquisition Corp. Alpha. References to our “management” or our “management team” refer to our officers and directors, and references to our “Sponsor” refer to SSAC Alpha Sponsor, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission (the “SEC”) on April 7, 2021, and the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, which was filed with the SEC on May 28, 2021. Except as expressly required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

This Management's Discussion and Analysis of Financial Condition and Results of Operations has been amended and restated to give effect to the restatement of our financial statements as of March 31, 2021 and June 30, 2021. Management identified errors made in its historical financial statements where, at the closing of our Initial Public Offering, we improperly valued our Class A common stock subject to possible redemption. We previously determined the Class A common stock subject to possible redemption to be equal to the redemption value of $10.00 per share of Class A common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Class A common stock issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company's control. Therefore, management concluded that the redemption value should include all Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has noted a reclassification error related to temporary equity and permanent equity.

Overview

We are a blank check company incorporated as a Delaware corporation on October 22, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as a Business Combination. We completed our initial public offering (our “IPO”) on January 28, 2021, which is described below under “—Liquidity and Capital Resources.”

While we may pursue a business combination target in any industry, we currently intend to focus our search for a target business in the direct-to-consumer brands, direct-to-consumer-services and mobile and social entertainment sectors. Since completing our IPO, we have reviewed, and continue to review, a number of opportunities to enter into a Business Combination with an operating business, but we are not able to determine at this time whether we will complete a Business Combination with any of the target businesses that we have reviewed or with any other target business. We intend to effectuate a Business Combination using cash from the proceeds of our IPO and the sale of the Private Placement Warrants (as defined below), our capital stock, debt, or a combination of cash, stock and debt.

Table of Contents

Results of Operations

For the three and nine months ended September 30, 2021, we had net income of $1.1 million and a net loss of $1.5 million, respectively. Our business activities during the three and nine months ended September 30, 2021 consisted primarily of organizational activities and those necessary to prepare for and complete our IPO and, subsequent to our IPO, identifying and evaluating prospective acquisition candidates for a Business Combination. We believe that we have sufficient funds available to complete our efforts to effect a Business Combination with an operating business by January 28, 2023. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination.

We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account (as defined below). We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence and other expenses in connection with searching for a target and completing a Business Combination.

Liquidity and Capital Resources

As of September 30, 2021, we had approximately $0.738 million in our operating bank account, and working capital of approximately $.737 million.

Our liquidity needs up to the completion of our IPO on January 28, 2021 had been satisfied through a payment from our Sponsor of $25,000 for 7,762,500 shares (the “Founder Shares”) of our Class B common stock and a loan of $300,000 from our Sponsor, which was repaid on February 2, 2021.

On January 28, 2021, we consummated our IPO of 31,050,000 units (the “Units”), including the issuance of 4,050,000 Units as a result of the underwriter’s full exercise of its over-allotment option. Each Unit consists of one share of our Class A common stock and one-third of one warrant of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $310,500,000. Simultaneously with the closing of our IPO, we completed the private sale of an aggregate of 5,473,333 private placement warrants (the “Private Placement Warrants”) to our Sponsor at a purchase price of $1.50 per private placement warrant, generating gross proceeds to us of $8,210,000.

A total of $310,500,000, comprised of the net proceeds of the IPO and the sale of the Private Placement Warrants, was placed in a U.S.-based trust account (the “Trust Account”) at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Transaction costs for the IPO and the sale of the Private Placement Warrants amounted to $17,495,500 consisting of $6,210,000 of underwriting fees, $10,867,500 of deferred underwriting fees and $418,000 of other offering costs. In addition, as of September 30, 2021, approximately $0.738 million of cash was held outside of the Trust Account and is available for working capital purposes.

As of September 30, 2021, we had marketable securities held in the Trust Account of $310,538,740 (including approximately $38,740 of interest income and unrealized gain) consisting of U.S. Treasury Bills with a maturity of 180 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes.

For the nine months ended September 30, 2021, cash used in operating activities was $1,359,303. Net loss of $1,490,551 was affected by a loss on the change in fair value of our warrant liability of $93,677 and interest on marketable securities held in the trust account of $38,740. Changes in operating assets and liabilities used $76,311 of cash for operating activities.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be net of taxes payable and excluding deferred underwriting commissions, to complete our Business Combination. We may make permitted withdrawals from the Trust Account to pay our taxes, including franchise taxes and income taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

Table of Contents

We intend to use funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business combination, and to pay taxes to the extent the interest earned on the Trust Account is not sufficient to pay our taxes.

In order to fund working capital deficiencies or finance transaction costs in connection with an intended Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. If we complete our Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. Otherwise, such loans may be repaid only out of funds held outside the Trust Account. In the event that our Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants issued to our Sponsor. As of September 30, 2021, there were no amounts outstanding under any such working capital loans.

Management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or at least through November 30, 2022. However, we may need to raise additional funds in order to meet the expenditures required for operating our business. If our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as described below.

We have an agreement to pay an affiliate of our Sponsor a monthly fee of $10,000 for office space and administrative and support services provided to the Company. We began incurring these fees on February 1, 2021 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.

The underwriter of the IPO is entitled to a deferred discount of $0.35 per Unit, or $10,867,500 in the aggregate. The deferred discount will become payable to the underwriter from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are a smaller reporting company as defined by Rule 12b-2 under the Exchange Act and are not required to provide the information otherwise required under this item.

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, and in light of the material weaknesses in internal controls described below, our Chief Executive Officer and Chief Financial Officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective due to the material weaknesses in our internal controls over financial reporting related primarily to the Company's accounting for complex financial instruments.

Our internal control over financial reporting did not result in the proper accounting classification and valuation of complex financial instruments, including warrants and shares subject to possible redemption, we issued in January 2021 which, due to its impact on our financial statements, we determined to be a material weakness.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended September 30, 2021 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, with the exception of the below.

The Chief Executive Officer and Chief Financial Officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for complex financial instruments. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be involved in various claims and legal actions in the ordinary course of business. We are not currently involved in any material legal proceedings outside the ordinary course of our business.

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2020 and in our Quarterly Report on Form 10-Q for the period ended March 31, 2021.

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Use of Proceeds

On January 28, 2021, we consummated our IPO of 31,050,000 Units, including the issuance of 4,050,000 Units as a result of the underwriter’s full exercise of its over-allotment option. Each Unit consists of one share of our Class A common stock and one-third of one warrant of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of our Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Units were sold at a price of $10.00 per unit, generating aggregate gross proceeds to the Company of $310,500,000. Credit Suisse Securities (USA) LLC acted as a sole underwriter of our IPO. The securities sold in our IPO were registered under the Securities Act on registration statements on Form S-1 (File Nos. 333-251987 and 333-252416). The registration statements became effective on January 25, 2021.

Following our IPO and the sale of the Private Placement Warrants, a total of $310,500,000 of the net proceeds from the sale of the Units and Private Placement Warrants was deposited in the Trust Account. Transaction costs amounted to $17,495,500, consisting of $6,210,000 of underwriting discounts and commissions, $10,867,500 of deferred underwriting discounts commissions and $418,000 of other cash offering costs. In addition, as of September 30, 2021, $0.7 million of cash was held outside of the Trust Account and is available for working capital purposes.

For a description of the use of the net proceeds from our IPO, see Part I, Item 2 of this Quarterly Report.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Table of Contents

Item 6. Exhibits


Exhibit Number		Description
3.1		Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 29, 2021).

3.2		Bylaws (incorporated by reference to Exhibit 3.3 filed with the Form S-1 filed by the Registrant on January 8, 2021).

4.1		Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 filed with the Form S-1/A filed by the Registrant on January 20, 2021).

4.2		Specimen Share of Class A common stock Certificate (incorporated by reference to Exhibit 4.2 filed with the Form S-1/A filed by the Registrant on January 20, 2021).

4.3		Specimen Warrant Certificate (included in Exhibit 4.4) (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 29, 2021).

4.4		Warrant Agreement, dated January 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 29, 2021).

31.1*		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101*		The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Condensed Balance Sheets; (ii) Condensed Statement of Operations; (iii) Condensed Statement of Changes in Stockholders’ Equity; (iv) Condensed Statement of Cash Flows; and (v) Notes to Condensed Financial Statements.

104*		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*Filed herewith

**Furnished herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	Science Strategic Acquisition Corp. Alpha

Date: November 15, 2021	By:	/s/ Michael Jones
		Mr. Michael Jones
		Chief Executive Officer
		(principal executive officer)

Date: November 15, 2021	By:	/s/ Thomas Dare
		Mr. Thomas Dare
		Chief Financial Officer
		(principal financial and accounting officer)

Science Strategic Acquisition Corp. Alpha 10-Q